Ramucirumab, as an advanced biologic, offers a new treatment option for patients with specific diseases. This article will introduce the relevant information of Ramucirumab in detail from four aspects: efficacy, dosage and precautions.
Detailed instructions for Ramucirumab: efficacy, dosage, precautions
Medical insurance prices and manufacturers
Ramucirumab, also known as Cyramza, Xiranze, etc., is produced by Eli Lilly in the United States. The specification of the original drug exported to Turkey is 100mg*2 sticks. In China, although Ramucirumab has been marketed, it has not yet been included in the medical insurance, and there are no generic drugs available on the market.
Patients should choose medication reasonably according to their own financial situation and doctor's advice.
The efficacy
Ramucirumab is mainly used to treat adult patients with specific diseases such as some gastric diseases and lung diseases. It exerts a therapeutic effect by targeting specific antigens, providing new therapeutic hope for patients with these diseases.
However, the exact response to the drug may vary from person to person, and patients should follow their doctor's instructions and evaluate the effectiveness of the treatment regularly.
Usage and dosage
The recommended dose of Ramucirumab is 8mg/kg every 2weeks by intravenous infusion over a 60-minute infusion period. If the first infusion is well tolerated, subsequent infusions can be completed within 30minutes. Patients should continue the drug until disease worsens or unacceptable toxicity occurs.
Proper dosage is key to ensuring efficacy and reducing side effects, and it is important for patients to follow their doctor's instructions and take their medications on time and in the right amount.
Precautions
When taking Ramucirumab, patients need to be aware of the following:
Serious adverse reactions
Ramucirumab may cause serious arterial thromboembolic events, such as myocardial infarction and cardiac arrest. Therefore, patients should pay close attention to their condition during the medication and seek medical attention immediately if there is any abnormality.
Medication for special populations
Pregnant women, lactating women, and women of reproductive potential and men of reproductive potential need to be used with special caution when using Ramucirumab. Based on animal studies and the drug's mechanism of action, Ramucirumab may cause damage to the fetus and fertility. Therefore, these special populations should consult their doctor before taking medication and follow their doctor's instructions for medication or contraception.
Drug interactions
Patients should inform their doctor about other drugs they are taking when taking Ramucirumab to avoid drug interactions. Especially when used in combination with drugs such as paclitaxel, close attention should be paid to the interaction between drugs and possible side effects.
As a novel biologic, Ramucirumab provides a new treatment option for patients with specific diseases. However, it is important for patients to follow their doctor's instructions and pay close attention to their condition during the medication process
